A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: Gemcitabine|DRUG: Paclitaxel|DRUG: Docetaxel
Sponsor: Eli Lilly and Company